Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.45 USD | +2.94% |
|
-15.22% | -11.55% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.55% | 85.32M | |
+56.37% | 816B | |
+39.48% | 634B | |
-7.46% | 351B | |
+16.10% | 323B | |
+6.99% | 293B | |
+13.32% | 238B | |
+0.82% | 222B | |
+13.35% | 218B | |
+8.18% | 167B |
- Stock Market
- Equities
- CLRB Stock
- News Cellectar Biosciences, Inc.
- Oppenheimer Adjusts Cellectar Biosciences Price Target to $10 From $11, Maintains Outperform Rating